Metropolitan Life Insurance Company (MetLife)’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,136
| Closed | -$202K | – | 1142 |
|
|
2024
Q1 | $202K | Sell |
1,136
-110
| -9% | -$19.6K | 0.01% | 715 |
|
|
2023
Q4 | $155K | Hold |
1,246
| – | – | 0.01% | 864 |
|
|
2023
Q3 | $145K | Buy |
1,246
+76
| +6% | +$8.82K | 0.01% | 832 |
|
|
2023
Q2 | $137K | Buy |
1,170
+43
| +4% | +$5.05K | 0.01% | 860 |
|
|
2023
Q1 | $90.2K | Sell |
1,127
-156
| -12% | -$12.5K | ﹤0.01% | 1044 |
|
|
2022
Q4 | $102K | Hold |
1,283
| – | – | ﹤0.01% | 1047 |
|
|
2022
Q3 | $89.4K | Hold |
1,283
| – | – | ﹤0.01% | 1074 |
|
|
2022
Q2 | $84.2K | Hold |
1,283
| – | – | ﹤0.01% | 1168 |
|
|
2022
Q1 | $85.4K | Sell |
1,283
-3,503
| -73% | -$233K | ﹤0.01% | 1294 |
|
|
2021
Q4 | $335K | Hold |
4,786
| – | – | ﹤0.01% | 1678 |
|
|
2021
Q3 | $250K | Buy |
4,786
+91
| +2% | +$4.75K | ﹤0.01% | 1908 |
|
|
2021
Q2 | $319K | Buy |
4,695
+311
| +7% | +$21.1K | ﹤0.01% | 1810 |
|
|
2021
Q1 | $338K | Sell |
4,384
-238
| -5% | -$18.3K | 0.01% | 1675 |
|
|
2020
Q4 | $277K | Hold |
4,622
| – | – | ﹤0.01% | 1723 |
|
|
2020
Q3 | $199K | Hold |
4,622
| – | – | ﹤0.01% | 1779 |
|
|
2020
Q2 | $191K | Buy |
4,622
+1,360
| +42% | +$56.3K | ﹤0.01% | 1824 |
|
|
2020
Q1 | $141K | Hold |
3,262
| – | – | ﹤0.01% | 1807 |
|
|
2019
Q4 | $181K | Hold |
3,262
| – | – | ﹤0.01% | 1992 |
|
|
2019
Q3 | $113K | Buy |
3,262
+2,551
| +359% | +$88.6K | ﹤0.01% | 2231 |
|
|
2019
Q2 | $28.6K | Buy |
+711
| New | +$28.6K | ﹤0.01% | 2556 |
|